Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Tipo de pagamento: L/C,T/T
Incoterm: FOB,CFR,CIF,EXW
A CS-274 foi aprovada pelos Estados Unidos e pela União Européia em 2003 a serem utilizadas em combinação com outros medicamentos anti-eméticos para prevenir náuseas agudas ou atrasadas durante o tratamento inicial ou repetido de tumores de vômitos altos ou moderados e vômitos.
Grupo de Produto : Intermediários de API > Intermediário para CAS 170729-80-3
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.